Adverum Biotechnologies is a clinical-stage gene therapy company targeting unmet medical need in ocular and rare diseases. The company develops gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company's main capabilities include clinical development, vector discovery, and in-house manufacturing expertise, specifically in scalable process development, assay development, and current Good Manufacturing Practices quality control. The company is conducting a clinical trial for its gene therapy candidate ADVM-022, AAV.7m8-aflibercept, for the treatment of wet age-related macular degeneration.

American Assets Trust is a self-administered real estate investment trust that owns, operates, acquires and develops retail, office, multifamily and mixed-use properties in Southern California, Northern California, Oregon, Washington, Texas and Hawaii. The company operates in four segments: Retail, which primarily include rental of retail space and other tenant services, including tenant reimbursements, parking and storage space rental; Office, which primarily include rental of office space and other tenant services; Multifamily, which include rental of apartments and other tenant services; and Mixed-use, which include rental of retail space and other tenant services.

Barnes & Noble Education is a contract operator of physical and virtual bookstores for college and university campuses and K-12 institutions. The company is also a textbook wholesaler, inventory management hardware and software provider, and a provider of digital education solutions. The company's segments are: Retail, which provides a range of course materials, including new and used print and digital textbooks; Wholesale, which provides a selection of new and used textbooks as well as sells hardware and a software suite of applications that provides inventory management and point-of-sale solutions; and DSS, which includes direct-to-student product and service to assist students to study.

HealthEquity provides technology-enabled services platforms that enable consumers to make healthcare saving and spending decisions. The company's platform provides an ecosystem where consumers can access their tax-advantaged healthcare savings, compare treatment options and pricing, evaluate and pay healthcare bills, receive personalized benefit and clinical information, earn wellness incentives, and make educated investment choices to grow their tax-advantaged healthcare savings. The company's products and services include healthcare saving and spending platform; health savings accounts; investment platform and advisory services, reimbursement arrangements; and HealthEquity retirement.

Kinder Morgan is an energy infrastructure company. The company's segments are: Natural Gas Pipelines, which includes the ownership and operation of, among others, main interstate and intrastate natural gas pipeline and storage systems; Products Pipelines, which includes the refined petroleum products, crude oil and condensate pipelines; Terminals, which includes the ownership and/or operation of, among others, liquids and bulk terminal facilities; and carbon dioxide (CO2), which includes the production, transportation and marketing of CO2, ownership interests in and/or operation of oil fields and gasoline processing plants in West Texas.

Kingsway Financial Services is a holding company. Through its subsidiaries, Co. operates as a merchant bank engaged in the property and casualty insurance business. Co. operates three segments: Insurance Underwriting, which markets automobile insurance products that provide coverage in three main areas: liability, accident benefits and physical damage; Insurance Services, which includes IWS Acquisition Corporation, a licensed motor vehicle service agreement company, and Trinity Warranty Solutions LLC, a provider of warranty products and maintenance support; and Leased Real Estate, which includes Co.'s subsidiary, CMC Industries, Inc., that owns a parcel of real property located in Texas.

Nautilus Marine Services' principal activity is the acquisition of offshore service vessels and technology and the provision of offshore oil services. In 2016, Co. operated two operating segments, the Bolivar Contract area and the Bocachico Contract area in the Magdalena Valley of Colombia, South America. The primary function of Co.'s segments is the development and sale of hydrocarbons and related activities in Colombia.

CUI Global is a platform company engaged in the acquisition, development and commercialization of new technologies and businesses. The company's operations fall into these reportable segments: Power and Electromechanical segment, which provides electronic components including power supplies, transformers, converters, connectors and industrial controls for original equipment manufacturers through its subsidiaries; and Energy Segment, which has developed a portfolio of products, services and resources to provide a range of personalized gas engineering solutions to the gas utilities, power generation, emissions, manufacturing and automotive industries through its subsidiaries.

Phreesia is a provider of comprehensive solutions that transform the healthcare experience by engaging patients in their care and enabling healthcare provider organizations to optimize operational efficiency, improve profitability and enhance clinical care. Through the SaaS-based Phreesia Platform (the "Phreesia Platform"), the company offers healthcare provider organizations a robust suite of solutions to manage the patient intake process and an integrated payments solution for secure processing of patient payments. The company's Platform also provides life sciences companies with an engagement channel for targeted and direct communication with patients.

Radius Health is a biopharmaceutical company focused on developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company's commercial product, TYMLOSTM (abaloparatide) injection is designed for the treatment of postmenopausal women with osteoporosis at high risk for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy. The company is developing an abaloparatide transdermal patch for potential use in the treatment of postmenopausal women with osteoporosis. The company is also developing its Elacestrant, a selective estrogen receptor degrader, for potential use in the treatment of hormone receptor-positive breast cancer.

Weis Markets is engaged in the retail sale of food in Pennsylvania. The company's retail food stores sell groceries, dairy products, frozen foods, meats, seafood, fresh produce, floral, pharmacy services, deli products, prepared foods, bakery products, beer and wine, fuel and general merchandise items, such as health and beauty care and household products. The store product selection includes national, local and private brands including natural, gluten-free and organic varieties. All retail food store locations operate as conventional supermarkets. The company utilizes a loyalty marketing program, Weis Club Preferred Shopper, which enable customers to receive discounts, promotions and fuel rewards.